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The Changing Face of Heroin Use in the United States
A Retrospective Analysis of the Past 50 Years
Theodore J. Cicero, PhD; Matthew S. Ellis, MPE; Hilary L. Surratt, PhD; Steven P. Kurtz, PhD
IMPORTANCE Over the past several years, there have been a number of mainstream media
reports that the abuse of heroin has migrated from low-income urban areas with large
minority populations to more affluent suburban and rural areas with primarily white
populations.
OBJECTIVE To examine the veracity of these anecdotal reports and define the relationship
between the abuse of prescription opioids and the abuse of heroin.
DESIGN, SETTING, AND PARTICIPANTS Using a mixed-methods approach, we analyzed (1) data
from an ongoing study that uses structured, self-administered surveys to gather
retrospective data on past drug use patterns among patients entering substance abuse
treatment programs across the country who received a primary (DSM-IV) diagnosis of heroin
use/dependence (n = 2797) and (2) data from unstructured qualitative interviews with a
subset of patients (n = 54) who completed the structured interview.
MAIN OUTCOMES AND MEASURES In addition to data on population demographics and
current residential location, we used cross-tabulations to assess prevalence rates as a
function of the decade of the initiation of abuse for (1) first opioid used (prescription opioid or
heroin), (2) sex, (3) race/ethnicity, and (4) age at first use. Respondents indicated in an
open-ended format why they chose heroin as their primary drug and the interrelationship
between their use of heroin and their use of prescription opioids.
RESULTS Approximately 85% of treatment-seeking patients approached to complete the
Survey of Key Informants’ Patients Program did so. Respondents who began using heroin in
the 1960s were predominantly young men (82.8%; mean age, 16.5 years) whose first opioid
of abuse was heroin (80%). However, more recent users were older (mean age, 22.9 years)
men and women living in less urban areas (75.2%) who were introduced to opioids through
prescription drugs (75.0%). Whites and nonwhites were equally represented in those
initiating use prior to the 1980s, but nearly 90% of respondents who began use in the last
decade were white. Although the “high” produced by heroin was described as a significant
factor in its selection, it was often used because it was more readily accessible and much less
expensive than prescription opioids.
CONCLUSION AND RELEVANCE Our data show that the demographic composition of heroin
users entering treatment has shifted over the last 50 years such that heroin use has changed
from an inner-city, minority-centered problem to one that has a more widespread
geographical distribution, involving primarily white men and women in their late 20s living
outside of large urban areas.
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I n recent years, there have been a number of mainstreammedia reports that the abuse of heroin has migrated fromlow-income urban areas with large minority populations
to more affluent suburban and rural areas with primarily white
populations.1-8 Large-scale epidemiological studies have docu-
mented significant increases in heroin use9,10 and overdose-
related hospitalizations9,11 nationwide, particularly over the
past 10 years, but there have been few systematic studies on
the demographics of today’s heroin users compared with those
who used heroin 40 to 50 years ago who were primarily young
men from minority groups living in urban areas.12-19
Part of this increase in heroin use and apparent migration
to a new class of users appears to be due to the coincidental
increase in the abuse of prescription opioids over the last 20
years,11,12,20-23 arguably accelerated by the release of OxyContin
in the mid-1990s,24,25 which made large quantities of oxyco-
done hydrochloride readily available for inhalation and intra-
venous injection. Given that prescription opioids are legal,
are prescribed by a physician, and are thus considered trust-
worthy and predictable (eg, the dose is clearly specified on a
distinctive tablet or pill), many users viewed these drugs as
safer to use than other illicit substances.26,27 However, there
is now growing evidence that some prescription opioid abus-
ers, particularly those who inhale or inject their drugs, gradu-
ate or shift to heroin,12,21,24,25,28-33 at least in part because it
has become more accessible and far less expensive than pre-
scription opioids.12,28,33-37 Thus, one could assume that more
recent users of heroin would share more demographic fea-
tures with today’s prescription opioid abusers than with
those individuals who initiated their heroin use 40 to 50
years ago.
To assess this postulate, we used a mixed-methods
approach, analyzing data from (1) an ongoing study using
structured, self-administered surveys to gather retrospective
data on drug use patterns among patients entering substance
abuse treatment programs across the country who received a
primary (DSM-IV) diagnosis of heroin use/dependence
(n = 2797) and from (2) unstructured qualitative interviews
with a subset of patients (n = 54) who completed the struc-
tured interview.
Methods
Study Sample
Our study used data from the ongoing nationwide Survey of
Key Informants’ Patients (SKIP) Program, a key element of the
postmarketing Researched Abuse, Diversion and Addiction-
Related Surveillance (RADARS) System.38 The SKIP Program
consists of more than 150 publicly and privately funded treat-
ment centers (key informants), balanced geographically with
coverage in 48 states, that recruit patients/clients to com-
plete an anonymous survey. Participants must be 18 years of
age or older and must meet DSM-IV criteria for substance abuse
with a primary drug that is an opioid (prescription drug or
heroin). Approximately 85% of patients approached by treat-
ment center staff agreed to complete the survey, which was
identified by a unique case number and sent directly to Wash-
ington University in St Louis, Missouri, by the respondent.
Participants were compensated with a $20 Walmart gift card.
The SKIP data were analyzed from third quarter 2010 to third
quarter 2013. Of 9346 opioid-dependent patients who com-
pleted the survey in that time frame, 2797 self-reported
heroin as their primary drug of abuse (eg, the drug used most
frequently in the month prior to treatment), the focus of the
present analysis.
To supplement and add context to the structured survey
in the SKIP Program, a subset of patients indicated (by mail-
ing in a postcard provided with the survey) that they were
willing to give up their anonymity and participate in an
unstructured interview-based study, which was named the
Researchers and Participants Interacting Directly (RAPID) pro-
gram. Based on the reflexive nature of qualitative research,
the purpose of this program is to develop a 2-way exchange of
information with participants through brief, periodic web-
based interviews, where questions can be developed, admin-
istered, and answered within a short time period to establish
real-time data. The collection period for this RAPID interview
was during the fourth quarter of 2013; 165 treatment clients
consented to participate in the study during this 3-month
period by completing and returning the anonymous survey,
with 54 of these clients indicating heroin as their a primary
drug of abuse. Participants in the RAPID program were com-
pensated with a $10 Visa check card. All protocols were
approved by the Washington University in St Louis institu-
tional review board.
Analyzed SKIP Variables
Substance Abuse
The SKIP respondents were asked to identify (1) the opioid
used most frequently in the past month to get high (eg, their
primary drug), stratified by opioid compound (eg, fentanyl,
heroin, or oxycodone), and (2) how often they abused their
primary drug (once a month, 2-4 times a month, once a
week, 2-4 times a week, once a day, more than once a day, or
more than 5 times a day). Respondents were asked at what
age they began abusing opioids regularly (≥2 times per week)
and were subsequently asked to specify, in their own words,
the first opioid they abused regularly. In addition, respon-
dents were asked to identify (1) all opioid compounds used
to get high in the month prior to treatment and (2) past-
month use of other substances for recreational/nonmedical
purposes (tobacco, alcohol more than 4 times in 1 day, mari-
juana, 3,4-methylenedioxymethamphetamien [MDMA, also
known as Ecstasy], cocaine or crack cocaine, methamphet-
amine [also known as crystal meth], hallucinogens, anti-
anxiety medications, sleep medications, muscle relaxants,
or antidepressants).
Demographic Variables
The survey in the SKIP Program includes the following demo-
graphic variables: (1) sex (male or female), (2) age (continu-
ous), (3) race/ethnicity (white, African American, Asian or Pa-
cific Islander, Native American; Latino, or other race), and (4)
self-declared area of current residence (large urban, small ur-
ban, suburban, or rural).
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RAPID Interviews
The RAPID participants were contacted to complete a self-
administered Internet-based questionnaire via SurveyMon-
key and, if applicable, participated in follow-up e-mail ex-
changes to clarify ambiguous responses and expound on
answers provided in the questionnaire. Other than demo-
graphics, participants were asked about their opioid abuse pat-
terns, and those that indicated both a primary drug of heroin
and past or current abuse of prescription opioids were asked
to explain, in an open-ended format, why they chose to use
heroin more frequently than prescription opioids. In addi-
tion, respondents were also asked to identify whether they
would prefer to abuse heroin or prescription opioids in a hy-
pothetical world where cost and accessibility would not limit
drug selection, and to subsequently explain their preference.
Data Analyses
To assess time-related changes in the demographic character-
istics of heroin users, we calculated the decade of a respon-
dent’s first regular opioid abuse using the following formula:
(year of survey completion − age at survey completion) + age
of first regular opioid abuse = year of first regular opioid abuse.
The year of first regular opioid abuse was then categorized by
its decade block starting from 1960 (1970, 1980, 1990, 2000,
and 2010).
Quantitative data in both SKIP and RAPID data sets were
analyzed using IBM SPSS Statistics version 20. The following
variables were transformed into binary measures (1/0): (1) first
opioid used (prescription opioid/heroin), (2) sex (male/
female), (3) race/ethnicity (white/nonwhite), and (4) area of resi-
dence (large urban/small urban and nonurban [suburban/
rural]). Also, in addition to population demographics, cross-
tabulations were used to assess prevalence rates as a function
of decade of first opioid use.
A review of the open-ended responses using the principles
of thematic analysis led to the identification of just 3 primary de-
cision-making factors involved in the selection and exclusion of
particular opioids as primary drugs of abuse: (1) ease of acces-
sibility, including monetary costs; (2) personal feelings on the
“high” provided by various opioids; and (3) ease of extraction
for inhalation and injection. Once these themes had been estab-
lished, NVivo version 9 (QSR International) was used to code the
presence of each theme (yes or no) in each individual response.
Results
Demographics of SKIP and RAPID Respondents
Our Table summarizes the gross demographic features of those
participating in the SKIP (n = 2757) and RAPID (n = 54) programs.
As can be seen, the RAPID subset, although much smaller, was
quite similar to the larger SKIP sample. The majority of respon-
dents who self-reported a primary drug of heroin were male,
white, and in their early 30s at the time of survey completion.
Residential Location and Drug Use Patterns
A much greater percentage of heroin users completing the sur-
vey in the SKIP Program reported currently living in small ur-
ban or nonurban areas than in large urban areas (75.2% vs
24.8%) at the time of survey completion. The sample of abus-
ers generally used heroin at least once a day (86.4%), had
abused other substances in the past month (98.5%), and had
concurrently abused prescription opioids in the 30 days prior
to treatment (66.0%).
Opioid Abuse Initiation
Figure 1 shows which opioids heroin users in the SKIP sample
first abused, as a function of the decade in which their opioid
abuse began. The number of users by decade ranged from 88
in the 1960s to more than 1600 in this century. Of those who
began their opioid abuse in the 1960s, more than 80% indi-
cated that they initiated their abuse with heroin. In a near com-
plete reversal, 75% of those who began their opioid abuse in
the 2000s reported that their first regular opioid was a pre-
scription drug. Beginning in 2010 (2010-2013), these trajecto-
ries showed a shift in direction (ie, heroin use increased as the
first opioid of abuse and prescription opioid use decreased),
although the data are based on only 3 years of data collection.
Shifts in Demographic Characteristics
As shown in Figure 2, heroin users who started their opioid
abuse in the 1960s were primarily men (82.8%). In contrast,
Table. Comparison of SKIP and RAPID Demographic Data
Characteristic
No. (%) of Respondents
SKIP
(n = 2757)
RAPID
(n = 54)
Male sex 1544 (56.0) 32 (58.5)
Age, mean (SEM), y 32.7 (0.2) 34.8 (1.5)
Race/ethnicity
White 2192 (79.5) 45 (83.3)
African American 270 (9.8) 5 (9.3)
Latino 154 (5.6) 2 (3.7)
Other 141 (5.1) 2 (3.7)
Abbreviations: RAPID, Researchers and Participants Interacting Directly;
SKIP, Survey of Key Informants’ Patients.
Figure 1. Percentage of the Total Heroin-Dependent Sample That Used
Heroin or a Prescription Opioid as Their First Opioid of Abuse
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the rate of women seeking treatment has increased in recent
decades, such that, in our sample, by 2010, there were nearly
equal numbers of male and female heroin users seeking treat-
ment. The ethnicity of heroin users seeking treatment also
showed a marked shift from nearly equal white to nonwhite
ratios in the 1960s to a dominance of white users (90.3%) by
2010 (Figure 3). Looking at age-related trends, as shown in
Figure 4, we found that the mean (SEM) age of heroin users
seeking treatment was 16.5 (0.3) years when they first began
abusing opioids in the 1960s. The mean (SEM) age at initia-
tion gradually increased over time to 22.9 (0.4) years in the de-
cade starting 2010.
Qualitative Studies
Although our quantitative data suggest that some heroin us-
ers who sought treatment between 2010 and 2013 began their
opioid abuse with heroin, most, particularly the vast major-
ity of those who started their abuse after 1990, did so with pre-
scription opioids (Figure 1). Given this strong association and
the contemporary epidemic of prescription opioid abuse, the
RAPID interview was focused on those who had past or cur-
rent abuse of prescription opioids but who, at the time of par-
ticipating, had a primary drug of heroin (n = 54). It should be
noted that every RAPID respondent who indicated heroin as
their primary drug also endorsed lifetime abuse of prescrip-
tion opioids.
Participants were asked to explain, in an open-ended for-
mat, why they more frequently used heroin than prescrip-
tion opioids. Using codes based on thematic analyses of re-
sponses, 98.1% of participants indicated that they considered
the “high” from heroin to be a determining factor in its use. A
third of these heroin users (31.7%) also mentioned that ease
of inhalation/injection, relative to prescription opioids that re-
quire extraction, was a practical factor in the selection of heroin
as a primary drug. Finally, nearly everyone (94%) indicated that
they used heroin because prescription opioids were far more
expensive and harder to obtain.
As one survey respondent stated: “Heroin is cheaper and
stronger than the prescription drugs listed, and the supply is
typically pretty consistent. It is also much easier to use intra-
venously than pills and other prescriptions, which often take
more complex methods to break down.”
This balance of “high” vs practical issues is illustrated in
those affected by the introduction of an abuse-deterrent
reformulation of OxyContin. As demonstrated elsewhere,20
the abuse-deterrent properties resulted in a sharp decrease
in the abuse of OxyContin, particularly by those who
injected or inhaled their drug. However, an unanticipated
outcome was increases in the abuse of other opioids, includ-
ing heroin.
As another survey respondent stated: “It [OxyContin] was
getting harder and harder to get the pills that you could use in
a needle, most of them would just ‘gel-up.’ And it was cheaper
and easier to get heroine [sic], which was much stronger and
would get you higher than Oxycodone.”
An important finding, not unrelated, was that nearly half
of the respondents (48.5%) who indicated a primary drug of
heroin actually preferred prescription opioids when pre-
sented with a hypothetical world where there were no limit-
ing factors to what drug they could have. These individuals de-
scribed the high of prescription opioids as “cleaner,” but they
used heroin instead because it was “cheaper” and “easier to
find,” even though its use presented legal problems not asso-
Figure 2. Sex Distribution of Respondents Expressed as Percentage
of the Total Sample
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Figure 3. Racial Distribution of Respondents Expressed as Percentage
of the Total Sample of Heroin Users
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Figure 4. Mean Age of Heroin Users When They First Used an Opioid
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ciated with prescription opioids. These complex relation-
ships are best illustrated by a representative quote from one
of our RAPID participants: “Started using and abusing oxy-
condone [sic] and changed to heroin because of the price.
Heroin is much cheaper than 30 mg pills of oxycondone [sic].
Although a person can still overdose it [oxycodone] is much
safer and cleaner than heroin. It is legal with a prescription and
wouldn’t have to worry about the consequences of getting
caught and the legal troubles that getting caught would cause.”
In addition, our qualitative data suggest that heroin use
has become common in populations that formerly only abused
prescription opioids. The following quotes not only exem-
plify this shift but also support our SKIP findings of demo-
graphic changes in those abusing heroin: “I knew I liked it
[heroin] above all else, and once I had a drug dealer it became
almost too easy to get, I had access to money because I am an
upper middle class family and I also became close to my deal-
ers, driving them around so I could get paid in drugs and just
becoming super close, even if it meant sexually, so I could get
the drug. The 2 dealers, and the people around them…are also
middle class white kids, not even kids we were all in the age
range of 25-41. It just became easy, and we weren’t really looked
at as being addicts because everyone thinks heroin addicts are
all homeless, shady looking, dirty junkies.”
Discussion
The results of these surveys indicate significant demo-
graphic differences between heroin users entering a treat-
ment program with a DSM-IV diagnosis of opioid depen-
dence who began their use of opioids in recent decades and
heroin users who initiated use 40 to 50 years ago. Moreover,
recent users of heroin were older, white men and women cur-
rently living primarily in nonurban areas who were intro-
duced to opioids through prescription drugs or who used
heroin as a cheaper and more accessible alternative to their pre-
ferred prescription opioid (eg, OxyContin). This contrasts
sharply to early studies12-19 that characterized the heroin prob-
lem as an inner-city issue among minority populations. Al-
though minority groups were predominant users in the 1960s
and 1970s, nearly 90% of respondents who began use in the
last decade were white. The shift in demographics of heroin
users over the last 2 decades can be most readily explained by
1 or more of 3 factors: first, the rapid increase in the use and
misuse of opioid prescription drugs in certain populations (ie,
white middle-class men and women in less urban areas) pre-
viously not exposed to opioids led to some experimentation
with heroin; second, and not unrelated, because of the high
cost of preferred prescription opioids, many users in our RAPID
program, as reported here and elsewhere,13,20,24-28 resorted to
the use of heroin, which is much cheaper and more acces-
sible; and finally, it appears that heroin use is now becoming
more common among current prescription opioid abusers.
An interesting aspect of our data is that the age at first opi-
oid use has increased over the past 50 years from 16 to 23 years
of age, although it must be noted that recall may be limited in
those reflecting back so long ago. Nonetheless, it would ap-
pear that today’s heroin users began their use at a much older
age than those who began 40 to 50 years ago. The reasons for
this are unclear but are likely due to the fact that prescription
opioids are much more readily available to younger individu-
als, particularly as an initial drug of abuse, given the common
belief that because prescription opioids are legal, they are con-
sidered trustworthy and predictable.26,27
There are important limitations to our studies. In terms of
our treatment-based sample, one could speculate whether or
not this population is representative of those using opioids “rec-
reationally,” particularly those who had access to the Internet
in order to participate in our web-based follow-up. Further-
more, many factors influence the decision to enter treat-
ment, such as family or court pressures and financial ability,
which makes the population even more selective, although it
is not clear that reasons for seeking treatment have changed
over the past 50 years. An additional limitation is that, al-
though there were sufficiently large numbers of patients for
each decade of initiation to draw meaningful conclusions, the
distribution was heavily skewed toward more recent users, as
would be expected in an aging population of this sort. How-
ever, this does lead to potential biases in terms of survival co-
horts or in terms of missing data from those who have ma-
tured out of their abuse. Finally, there are potential issues of
recall when discussing events that have occurred a number of
years ago, some of which could be significant. Obviously, how-
ever, recall is not an issue for several of our important covar-
iates (eg, ethnicity and sex). Nonetheless, a prospective study
following a cohort over decades would minimize some of these
issues, but such a study is simply not feasible and would be of
limited value in addressing contemporary issues. Thus, we feel
that a retrospective approach can serve a useful purpose in
identifying and understanding epidemiological shifts in the
abuse of heroin, as well as providing an impetus for future
studies.
Conclusions
Our surveys have shown a marked shift in the demographics
of heroin users seeking treatment over the past several de-
cades. We found that heroin use is not simply an inner-city
problem among minority populations but now extends to
white, middle-class people living outside of large urban areas,
and these recent users exhibit the same drug use patterns as
those abusing prescription opioids. In this connection, our data
indicate that many heroin users transitioned from prescrip-
tion opioids. The factors driving this shift may be related to
the fact that heroin is cheaper and more accessible than pre-
scription opioids, and there seems to be widespread accep-
tance of heroin use among those who abuse opioid products.
These latter conclusions are typified by a quote from one of
our interviewees, which highlights the importance of these
findings for future treatment and prevention efforts: “All of my
friends use heroin and I know multiple people who will sell it
to me or help me find someone who has it. Also if I have money
I wanna spend it on something I know will get me high. If I buy
pills I might not have enough money to make sure I get high.”
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